跳至主要内容
临床试验/NL-OMON54081
NL-OMON54081招募中不适用

Identifying the underlying mechanisms and consequences of the loss of nasal T cells in vital and frail older individuals - T cells in Nose of Older adults (TINO)

eids Universitair Medisch Centrum0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age, frailty score and self-reported respiratory tract infections in previous
  • year, ability to provide informed consent

排除标准

  • Incompetence to provide informed consent
  • Current smoker or >40 pack year history
  • History of severe nose bleedings
  • Diagnosed with asthma, COPD or chronic rhinosinusitis
  • Use of inhalation corticosteroids or antibiotics in the past 6 weeks
  • Current use of anti-coagulants (to prevent nosebleeds). Platelet inhibitors
  • like acetylsalicylzuur (Ascal) are allowed
  • Respiratory tract infection or common cold in the past 2 weeks
  • Immunocompromised individuals (with primary immune deficiency or secondary
  • immune deficiency)
  • Life expectancy <28 days in the opinion of study physician
  • Vaccination in the 2 months prior to study start

研究者

相似试验